The evaluation of a nurse-led Sacubitril/Valsartan initiation and titration clinic

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Andrew Brown

Wansbeck General Hospital, Ashington (United Kingdom of Great Britain & Northern Ireland)

9 More presentations in this session

Presentation thumbnail

Transcoronary transfer of Wharton's jelly mesenchymal pluripotent stem cells in patients with chronic ischaemic heart failure shows safety and unprecedented high-grade myocardial uptake

Doctor A. Kozynacka (Krakow, PL)

Presentation thumbnail

Effect of sacubitril-valsartan in reducing physical frailty in patients with advanced heart failure in waiting list for heart transplantation

Doctor G. Benincasa (Naples, IT)

Abstract Slides

Presentation thumbnail

Use of sacubitril-valsartan in an extensive long term follow up cohort in real life

Doctor A. Garcia Quintana (Palmas de Gran Canaria, Las, ES)

Abstract Slides

Presentation thumbnail

Changes in glycated hemoglobin in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan

Presentation thumbnail

Valsartan reduces level of soluble ST2 and left ventricle remodeling in patients with dual chamber pacemaker

Mrs E. Radzik (Zabrze, PL)

Access the full session

Session thumbnail

Poster Session 1 - Treatment of the chronic heart failure

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Presentation

Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion

Congress Presentation

The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources